Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 6 von 1157

Details

Autor(en) / Beteiligte
Titel
Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation
Ist Teil von
  • Oncotarget, 2016-05, Vol.7 (21), p.31014-31028
Ort / Verlag
United States: Impact Journals LLC
Erscheinungsjahr
2016
Quelle
MEDLINE
Beschreibungen/Notizen
  • Small cell lung cancer (SCLC) is the most aggressive type of lung cancer with high mortality. One of the MYC family genes, MYC, MYCL or MYCN, is amplified in ~20% of the SCLCs; therefore, MYC proteins are potential therapeutic targets in SCLC patients. We investigated the therapeutic impact of Omomyc, a MYC dominant negative, in a panel of SCLC cell lines. Strikingly, Omomyc suppressed the growth of all tested cell lines by inducing cell cycle arrest and/or apoptosis. Induction of G1 arrest by Omomyc was found to be dependent on the activation of CDKN1A, in part, through the TP73 pathway. Our results strongly indicate that SCLC cells carrying amplification of MYC, MYCL or MYCN are addicted to MYC function, suggesting that MYC targeting would be an efficient therapeutic option for SCLC patients.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX